Table 1.

Clinical characteristics of 30 patients with NSCLC studied for NK cell phenotype

PatientAgeSexTobacco (PY)HistologyTNM% NK cells% CD56dim% CD56bright
166FnaADCT1N0M01.794.15.9
269M50ADCT1N0M05.9991
341FnaADCT1N1M06.897.92.1
469M35ADCT1N1M03.7991
573MnaADCT1N2M016.790.89.2
657MnaADCT2N0M011.897.42.6
766M40ADCT2N0M07.740.759.3
839F20ADCT2N0M031.793.36.7
976M50ADCT2N0M034.427.872.2
1062M<10ADCT2N0M0696.53.5
1150F0ADCT2N0M04.7937
1258M40ADCT2N1M05.923.476.6
1372M20ADCT2N2M0695.34.7
1481MnaADCT2N2M0897.52.5
1579M70ADCT2N2M06.495.74.3
1650M35ADCT2N2M05.893.36.7
1745M40ADCT4N0M07.8891.98.1
1871MnaSCCT1N0M017298
1975MnaSCCT2N0M02.897.82.2
2076M25SCCT2N0M010.6964
2170M35SCCT2N1M07.599.40.6
2260M40SCCT2N1M010.697.22.8
2365M10SCCT2N2M010.398.41.6
2461F40SCCT3N0M08.193.36.7
2574M60SCCT4N2M05.694.95.1
2657M60LCCT2N2M02.676.923.1
2761MnaLCCT3N0M05.397.52.5
2857M40LCCT3N1M01.685.214.8
2968M50ADC/LCCT2N0M05.296.53.5
3057M10ADC/LCCT2N1M03.1991

NOTE: Pathologic staging and histologic types of lung cancer were determined according to the TNM staging system and to the histologic classification of the World Health Organization, respectively. The percentages of NK cells were determined by flow cytometry as CD3CD56+ cells. PY: Packs per year. LCC: large-cell carcinoma; na: data not available.